Lawmakers and patients are working to reduce the cost of enzalutamide.

Published Date: 02 Mar 2023

Members of Congress are scrambling to test whether Bayh-Dole's "walk-in" provisions for patents on federally-funded discoveries could lower the cost of certain drugs in the United States.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

2.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

3.

One possible target in acute myeloid leukemia is the reductive carboxylation of glutamine.

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

Mapping lifelong chronic health risks for childhood cancer survivors


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot